Health Canada will limit use of Ketek (telithromycin)

Health Canada will limit use of Ketek (telithromycin).

It's no longer approved for treating bronchitis, sinusitis, tonsillitis, or pharyngitis.

Health Canada says that these less serious infections don't justify Ketek's risks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote